Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Arsenic Trioxide in APL

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

Leukemia volume 14, pages 262–270 (2000)Cite this article

Abstract

Recent studies showed that arsenic trioxide (As2O3) could induce apoptosis and partial differentiation of leukemic promyelocytes. Here, we addressed the possible mechanisms underlying these two different effects. 1.0 μM As2O3-induced apoptosis was associated with condensation of the mitochondrial matrix, disruption of mitochondrial transmembrane potentials (ΔΨm) and activation of caspase-3 in acute promyelocytic leukemia (APL) cells regardless of their sensitivity to all-trans retinoic acid (ATRA). All these effects were inhibited by dithiothreitol (DTT) and enhanced by buthionine sulfoximine (BSO). Furthermore, BSO could also render HL60 and U937 cells, which had the higher cellular catalase activity, sensitive to As2O3-induced apoptosis. Surprisingly, 1.0 μM As2O3 did not induce the ΔΨm collapse and apoptosis, while 0.1 μM As2O3 induced partial differentiation of fresh BM cells from a de novo APL patient. In this study, we also showed that 0.2 mM DTT did not block low-dose As2O3-induced NB4 cell differentiation, and 0.10.5 μM As2O3 did not induce differentiation of ATRA-resistant NB4-derived sublines, which were confirmed by cytomorphology, expression of CD11b, CD33 and CD14 as well as NBT reduction. Another interesting finding was that 0.10.5 μM As2O3 could also induce differentiation-related changes in ATRA-sensitive HL60 cells. However, the differentiation-inducing effect could not be seen in ATRA-resistant HL60 sublines with RARα mutation. Moreover, low-dose As2O3 and ATRA yielded similar gene expression profiles in APL cells. These results encouraged us to hypothesize that As2O3 induces APL cell differentiation through direct or indirect activation of retinoic acid receptor-related signaling pathway(s), while ΔΨm collapse is the common mechanism of As2O3-induced apoptosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  1. Sun HD, Ma L, Hu XC, Zhang TD . Ai-Lin I treated 32 cases of acute promyelocytic leukemia Chin J Integrat of Chinese and Western Med 1992 12: 170–171

    Google Scholar 

  2. Zhang P, Wang SY, Hu XH . Arsenic trioxide treated 72 cases of acute promyelocytic leukemia Chin J Hematol 1996 17: 58–60

    Google Scholar 

  3. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qin QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou C, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY . Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II clinical efficacy and pharmacokinetics in relapsed patients Blood 1997 89: 3354–3360

    CAS  PubMed  Google Scholar 

  4. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, deBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP Jr . Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide New Engl J Med 1998 339: 1341–1348

    Article  CAS  Google Scholar 

  5. Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ, Chen Z . Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells Blood 1997 89: 3345–3353

    CAS  PubMed  Google Scholar 

  6. Kitamura K, Yoshida H, Ohno R, Naoe T . Toxic effects of arsenic and other metal ions on APL cells Intl J Hematol 1997 65: 179–185

    Article  CAS  Google Scholar 

  7. Gianni M, Koken MHM, Chelbi-Alix MK, Benoit G, Lanotte M, Chen Z, de The H . Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells Blood 1998 91: 4300–4310

    CAS  PubMed  Google Scholar 

  8. Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen, ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z . In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with down-regulation of Bcl-2 expression and alteration of PML-RARα/PML protein localization Blood 1996 88: 1052–1061

    CAS  PubMed  Google Scholar 

  9. Zhu J, Koken MH, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z, de The H . Arsenic-inducing PML targeting onto nuclear bodies: implications for the treatment of APL Proc Natl Acad Sci USA 1997 94: 3978–3983

    Article  CAS  Google Scholar 

  10. Andre C, Guillemin MC, Zhu J, Koken MH, Quignon F, Herve L, Chelbi-Alix MK, Dhumeaux D, Wang ZY, Degos L, Chen Z, de The H . The PML and PML/RARα domains: from autoimmuity to molecular oncology and from retinoic acid to arsenic Exp Cell Res 1996 229: 253–260

    Article  CAS  Google Scholar 

  11. Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH Jr . Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells J Natl Cancer Inst 1998 90: 124–133

    Article  CAS  Google Scholar 

  12. Look AT . Arsenic and apoptosis in the treatment of acute promyelocytic leukemia J Natl Cancer Inst 1998 90: 86–88

    Article  CAS  Google Scholar 

  13. de The H, Chomienne C, Lanotte D, Degos L, Dejean A . The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus Nature 1990 347: 558–566

    Article  CAS  Google Scholar 

  14. Kakizuka A, Miller WH Jr, Umesono K, Warrel RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM . Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML Cell 1991 66: 663–672

    Article  CAS  Google Scholar 

  15. Akao Y, Mizoguchi H, Kojima S, Naoe T, Ohishi N, Yagi K . Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein BrJ Haematol 1998 102: 1055–1060

    Article  CAS  Google Scholar 

  16. Zhang W, Ohnishi K, Shigeno K, Fujisawa S, Naito K, Nakamura S, Takeshita K, Takeshita A, Ohno R . The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms Leukemia 1998 12: 1383–1391

    Article  CAS  Google Scholar 

  17. Ishitsuka K, Hanada S, Suzuki S, Utsunomiya A, Chyuman Y, Takeuchi S, Takeshita T, Shimotakahara S, Uozumi K, Makino T, Arima T . Arsenic trioxide inhibits growth of human T-cellleukaemia virus type I infected T-cell lines more effectively thanretinoic acids Br J Haematol 1998 103: 721–728

    Article  CAS  Google Scholar 

  18. Zhu XH, Shen YL, Jing YK, Cai X, Jia PM, Huang Y, Tang W, Shi GY, Sun YP, Dai J, Wang ZY, Chen SJ, Zhang TD, Waxman S, Chen Z, Chen GQ . Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinicallyachievable concentrations J Natl Cancer Inst 1999 91: 772–778

    Article  CAS  Google Scholar 

  19. Rousselot P, Labaume S, Marolleau JP, Larghero J, Noguera MH, Brouet JC, Fermand JP . Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients Cancer Res 1999 59: 1041–1048

    CAS  PubMed  Google Scholar 

  20. Shen ZY, Tan LJ, Cai WJ, Shen J, Chen C, Tang XM, Zheng MH . Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro Int J Mol Med 1999 4: 33–37

    CAS  PubMed  Google Scholar 

  21. Akao Y, Nakagawa Y, Akiyama K . Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro FEBS Lett 1999 455: 59–62

    Article  CAS  Google Scholar 

  22. Larochette N, Decaudin D, Jacotot E, Brenner C, Marzo I, Susin SA, Zamzami N, Xie Z, Reed J, Kroemer G . Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore Exp Cell Res 1999 249: 413–421

    Article  CAS  Google Scholar 

  23. Gurr JR, Bau DT, Liu F, Lynn S, Jan KY . Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells Mol Pharmacol 1999 56: 102–109

    Article  CAS  Google Scholar 

  24. Li YP, Said F, Gallagher RE . Retinic acid-resistant HL60 cells exclusively contain mutant retinoic acid recepter-alpha Blood 1996 88: 2671–2682

    Google Scholar 

  25. Dai J, Weinberg RS, Waxman S, Jing YK . Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic through modulation of the glutathione Blood 1999 93: 268–277

    CAS  PubMed  Google Scholar 

  26. Liu TX, Zhang JW, Zhang RB, Wu JS, Tao J, Tong JH, Yu M, Sun YW, Lanotte M, Waxman S, Zhu L, Chen SJ, Chen Z, Mao M . Identification of the molecular pathways underlying the retinoic acid-induced differentiation of acute promyelocytic leukemia cells Blood 1998 92: 193a (Abstr.)

    Google Scholar 

  27. Wang ZG, Rivi R, Delva L, Konig A, Scheinberg DA, Gambacorti-Passerini C, Gabrilove JL, Warrell RP Jr, Pandolfi PP . Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner Blood 1998 92: 1497–1504

    CAS  PubMed  Google Scholar 

  28. Muller S, Matunis JM, Dejean A . Conjugation with ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus EMBO J 1998 17: 61–68

    Article  CAS  Google Scholar 

  29. Muller S, Miller WH Jr, Dejean A . Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells Blood 1998 92: 4308–4316

    CAS  PubMed  Google Scholar 

  30. Koken MH, Daniel MT, Gianni M, Zelent A, Licht J, Buzyn A, Minard P, Degos L, Varet B, de The H . Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient Oncogene 1999 18: 1113–1118

    Article  CAS  Google Scholar 

  31. Fanelli M, Minucci S, Gelmetti V, Nervi C, Gambacorti-Passerini C, Pelicci PG . Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance Blood 1999 93: 1477–1481

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by National Key Programme for Basic Research (973) National Natural Science Foundation of China (NNSFC) research grants No. 39970312 and No. 39730270 (GQC), and a NNSFC award for Outstanding Young Scientists (No. 39725011)(GQC), National Ministry of Public Health (GQC), Shanghai Municipal Foundation for Outstanding Young Researcher (GQC), Samuel Waxman Cancer Research Foundation and Clyde Wu Foundation of Shanghai Institute of Hematology.

Author information

Author notes

  1. X Cai and Y-L Shen: Cai X and Shen Y-L contributed equally to this work

Authors and Affiliations

  1. Shanghai Institute of Hematology, Rui-Jin Hospital, Shanghai Second Medical University, 197 Rui-Jin Road II, Shanghai, 200025, PR China

    X Cai, Y-L Shen, Q Zhu, P-M Jia, Y Yu, L Zhou, Y Huang, J-W Zhang, S-M Xiong, S-J Chen, Z-Y Wang, Z Chen & G-Q Chen

Authors
  1. X Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y-L Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Q Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P-M Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J-W Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S-M Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S-J Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Z-Y Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Z Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. G-Q Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cai, X., Shen, YL., Zhu, Q. et al. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 14, 262–270 (2000). https://doi.org/10.1038/sj.leu.2401650

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401650

Keywords

This article is cited by

Search

Advanced search

Quick links